Severe Oral Lichen Planus Masking a Primary Immunodeficiency: X‐Linked Lymphoproliferative Disease Type 1 ( <scp>XLP</scp> ‐1)

A 14-year-old boy was initially diagnosed with erosive oral lichen planus based on clinical and histopathological findings. However, the atypical clinical course and resistance to immunosuppressive therapy raised suspicion for an autoinflammatory disorder or inborn error of immunity. Genetic testing revealed a pathogenic SH2D1A mutation, confirming X-linked lymphoproliferative disease type 1 (XLP-1) in the absence of Epstein-Barr virus exposure. This case highlights oral mucosal lesions as a potential early, EBV-independent manifestation of XLP-1 and emphasizes the importance of considering monogenic immune disorders in persistent, treatment-refractory mucosal disease.

Authors

Institutions

Publication Details

Journal
Pediatric Dermatology
Published
2025-09-04
DOI
https://doi.org/10.1111/pde.70025
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe Oral Lichen Planus Masking a Primary Immunodeficiency: X‐Linked Lymphoproliferative Disease Type 1 ( XLP ‐1)

Clàudia Fortuny Guasch, Antonio Martínez, Eulàlia Baselga, Magí Brufau‐Cochs et al.
Pediatric Dermatology
Immunodeficiency and Autoimmune Disorders
article

Severe Oral Lichen Planus Masking a Primary Immunodeficiency: X‐Linked Lymphoproliferative Disease Type 1 ( XLP ‐1)

Clàudia Fortuny Guasch, Antonio Martínez, Eulàlia Baselga, Magí Brufau‐Cochs, Mariana Álvarez Vukov, Laura Martí‐Sánchez
article en

Abstract

A 14-year-old boy was initially diagnosed with erosive oral lichen planus based on clinical and histopathological findings. However, the atypical clinical course and resistance to immunosuppressive therapy raised suspicion for an autoinflammatory disorder or inborn error of immunity. Genetic testing revealed a pathogenic SH2D1A mutation, confirming X-linked lymphoproliferative disease type 1 (XLP-1) in the absence of Epstein-Barr virus exposure. This case highlights oral mucosal lesions as a potential early, EBV-independent manifestation of XLP-1 and emphasizes the importance of considering monogenic immune disorders in persistent, treatment-refractory mucosal disease.

Pediatric DermatologyVol. 43(1)
Hospital Sant Joan de Déu Barcelona (ES), Sant Joan de Déu Research Foundation (ES), Universitat de Barcelona (ES)
Openalex Percentile: Top 74%
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.